ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Man Group plc

Man Group plc lessened its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 76.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,197 shares of the medical instruments supplier's stock after selling 41,952 shares during the quarter. Man Group plc owned approximately 0.05% of ICU Medical worth $2,048,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in shares of ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier's stock valued at $416,176,000 after acquiring an additional 17,805 shares during the period. JPMorgan Chase & Co. grew its holdings in ICU Medical by 7.4% in the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier's stock valued at $109,920,000 after purchasing an additional 49,108 shares during the period. Dimensional Fund Advisors LP increased its position in shares of ICU Medical by 18.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock valued at $83,788,000 after buying an additional 82,982 shares in the last quarter. Northern Trust Corp raised its stake in shares of ICU Medical by 11.1% during the 4th quarter. Northern Trust Corp now owns 402,342 shares of the medical instruments supplier's stock worth $62,431,000 after buying an additional 40,187 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in shares of ICU Medical by 1.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock valued at $47,196,000 after buying an additional 3,048 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

ICU Medical Trading Down 1.0%

Shares of NASDAQ ICUI traded down $1.29 during trading on Wednesday, hitting $129.15. 28,445 shares of the company were exchanged, compared to its average volume of 276,578. The company has a fifty day moving average price of $138.87 and a 200-day moving average price of $151.88. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The firm has a market capitalization of $3.18 billion, a PE ratio of -28.23 and a beta of 0.87. ICU Medical, Inc. has a 12-month low of $100.91 and a 12-month high of $196.26.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 EPS for the quarter, topping analysts' consensus estimates of $1.23 by $0.49. The company had revenue of $599.49 million for the quarter, compared to the consensus estimate of $574.15 million. ICU Medical had a negative net margin of 4.74% and a positive return on equity of 5.05%. ICU Medical's quarterly revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.96 earnings per share. As a group, equities research analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current year.

Insider Activity

In related news, Director David C. Greenberg sold 1,942 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $143.66, for a total transaction of $278,987.72. Following the completion of the sale, the director now directly owns 6,760 shares of the company's stock, valued at approximately $971,141.60. This trade represents a 22.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 600 shares of the company's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $138.92, for a total transaction of $83,352.00. Following the completion of the transaction, the director now directly owns 3,252 shares in the company, valued at $451,767.84. The trade was a 15.58% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 26,167 shares of company stock valued at $3,571,788. 1.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ICUI. KeyCorp reduced their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Sunday, May 18th. Raymond James decreased their target price on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating on the stock in a research report on Friday, May 9th. Finally, Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, ICU Medical presently has an average rating of "Buy" and an average target price of $192.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.